Phase III trial of Alzheimer’s drug offers hope to patients...

Aug 13, 2016 by

Scientists have completed the first phase III clinical trial of a drug that targets a tau, the hallmark protein of Alzheimer’s the forms twisted fibers and neuron death....

read more